Rewards for cancer control with use of biologic markers and end points.
The increasing availability of biologic markers and end points offers significant potential for improvement in cancer control. These tools are underutilized today, but it is clear that they can be major assets to pathologists, clinicians, epidemiologists, and ultimately to programs designed for preventive or therapeutic intervention in populations and individuals at high cancer risk.